News tagged with malignancy
Related topics: cancer , breast cancer , prostate cancer , cancer cells , carcinoma
Stemming the spread of cancer
Okayama University's Masaharu Seno and colleagues have demonstrated in vitro the development of cancer stem cells (CSCs) from a type of normal stem cell exposed to their hypothetical microenvironment of a ...
Cancer
Sep 21, 2012 |
not rated yet |
0
Tissue around tumor holds key to fighting triple negative breast cancer
A natural substance found in the surrounding tissue of a tumor may be a promising weapon to stop triple negative breast cancer from metastasizing.
Cancer
Sep 19, 2012 |
5 / 5 (1) |
0
L-carnitine does not reduce cancer-related fatigue
(HealthDay)—Patients with invasive malignancies who take L-carnitine supplements do not experience a reduction in fatigue, pain, or depression, according to research published online Sept. 17 in the Journal of ...
Cancer
Sep 18, 2012 |
not rated yet |
0
Cloned receptor paves way for new breast and prostate cancer treatment
Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability ...
Cancer
Sep 13, 2012 |
4 / 5 (4) |
0
|
Geneticists verify cholesterol-cancer link
University of Rochester Medical Center scientists discovered new genetic evidence linking cholesterol and cancer, raising the possibility that cholesterol medications could be useful in the future for cancer prevention or ...
Medical research
Sep 13, 2012 |
5 / 5 (1) |
0
|
HIF gene mutation found in tumor cells offers new clues about cancer metabolism
For the first time, a mutation in HIF2α, a specific group of genes known as transcription factors that is involved in red blood cell production and cell metabolism, has been identified in cancer tumor cells.
Cancer
Sep 06, 2012 |
5 / 5 (1) |
0
Cancer researchers discover gene defect responsible for cancer syndrome
University of Hawai'i Cancer Center researchers have discovered germline BAP1 mutations are associated with a novel cancer syndrome characterized by malignant mesothelioma, uveal melanoma, cutaneous melanoma and atypical ...
Cancer
Sep 06, 2012 |
not rated yet |
0
Epigenetic causes of prostate cancer
(Medical Xpress)—In about half of all prostate tumours, there are two genetic areas that are fused with one another. When this is not the case, the exact way cancer cells originate in prostate tumours was not clear until ...
Cancer
Sep 05, 2012 |
5 / 5 (2) |
0
A sad legacy—Victims of childhood asbestos exposure
(Medical Xpress)—"Wittenoom kids" who spent their childhoods exposed to asbestos in the north-west of Western Australia are now developing a range of cancers or dying at a rate well above the average population, ...
Cancer
Sep 04, 2012 |
not rated yet |
1
Potential drug for treating deadly brain cancer
(Medical Xpress)—A*STAR scientists have identified a biomarker of the most lethal form of brain tumours in adults − glioblastoma multiforme. The scientists found that by targeting this biomarker and depleting ...
Cancer
Sep 04, 2012 |
5 / 5 (2) |
0
|
Study pinpoints malignant mesothelioma patients likely to benefit from drug pemetrexed
Previous studies have hypothesized that low levels of the enzyme thymidylate synthase (TS) likely mark patients who will benefit from the drug pemetrexed – but results have been inconclusive at best and at times contradictory. ...
Cancer
Aug 29, 2012 |
not rated yet |
0
|
Survival statistics show hard fight when malignant brain tumors appear at multiple sites
LOS ANGELES (Embargoed until 10 a.m. EDT on Aug. 24, 2012) – When aggressive, malignant tumors appear in more than one location in the brain, patient survival tends to be significantly shorter than when the disease starts ...
Neuroscience
Aug 24, 2012 |
not rated yet |
0
|
DNA deletions promote cancer, collateral damage makes it vulnerable
Genomic deletions promote cancer by carving up or eliminating tumor-suppressor genes, but now scientists report in the journal Nature that the collateral damage they inflict on neighboring genes exposes cancer cells to vul ...
Cancer
Aug 15, 2012 |
4.5 / 5 (2) |
0
|
Study: Vaccine targets malignant brain cancer antigens, significantly lengthens survival
An experimental immune-based therapy more than doubled median survival of patients diagnosed with the most aggressive malignant brain tumor, Cedars-Sinai Medical Center researchers reported in Cancer Immunology, Im ...
Immunology
Aug 15, 2012 |
5 / 5 (1) |
0
|
Rat study shows chrysotile asbestos is strong carcinogen
(HealthDay) -- Chrysotile, a commercially used type of asbestos, induces malignant mesothelioma (MM) in the rat peritoneal cavity, with pathogenesis strongly linked to iron overload, according to a study ...
Medical research
Aug 14, 2012 |
2 / 5 (2) |
0
